Best Life Sciences Companies in Canton of Bern, Switzerland
The 31 best Life Sciences companies in Canton of Bern, Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: LEM Surgical.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Canton of Bern
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Alpine Dynamics Developer of therapeutic candidates using artificial intelligence-driven molecular simulations for genetic… | — | — | Unfunded | — | Murat Kılıç CEO | — | — | — |
| 2 | ARCTOS medical Developer of optogenetic therapies for treating retinal degenerative diseases | — | — | Acquired | 1 | — | — | 11 patents Engineered light‑responsive chimeric GPCR proteins for optogenetic therapeutics | — |
| 3 | Basisnote DNA matchmaking portal | — | — | Deadpooled | — | Dominic Senn Co-Founder & ex-CEO | — | 6 patents MHC-based odor profiling for personalized fragrance and mate selection | — |
| 4 | Bernafon Developer of commercialized hearing aids | — | — | Unfunded | 148 | Erich Spahr CEO | — | 223 patents Advanced hearing aid signal processing, feedback cancellation, and acoustic damping technologies. | — |
| 5 | Erib Corp Provider of wearables, swallowable biosensors and apps for monitoring food intake | — | — | Unfunded | — | Erwin Richard Founder & CEO | — | — | — |
| 6 | Finox Biotech Swiss biopharma company developing fertility products. | — | — | Acquired | 51 | Gavin Jelic-Masterton CEO | — | — | — |
| 7 | GenPAx Provider of a bacterial genome sequencing platform for data analysis | — | — | Unfunded | — | Julian Hardy Chief Executive Officer & Co Founder | — | — | — |
| 8 | Meridian Medical Developer of laser and imaging systems for ophthalmological conditions | — | — | Unfunded | — | Eric Odenheimer CEO | Wix eCommerceWixSentry+14 | — | — |
Top 12 Life Sciences companies in Canton of Bern
#1
Funding Raised · Bern, Canton of Bern · founded 2020 · 3 employees$996.1Kraised▾
{}
- Jan 2026Grant (prize money)$996.1K
#2
Seed · Bern, Canton of Bern · founded 2021$3.1Mraised▾
Developer of an external ventricular drain to decrease intracranial pressure. The company develops products that are thin catheters that are inserted into brain cavities (ventricles) to measure intracranial pressure and drain fluid to decrease it.
- Aug 2025Seed$2.9M
- Dec 2022Grant (prize money)$161.1K
#3
Seed · Bern, Canton of Bern · founded 2019 · 16 employees$4.8Mraised▾
Developer of a device for the diagnosis of brain disease. It offers NeurOphthalmoscope a diagnostic device for an automated, objective, and quantifiable analysis of brain functions related to the visual system.
- Mar 2025Seed—
- Sep 2022Seed$3.3M
- Dec 2021Seed$1.5M
#4
Series B · Bern, Canton of Bern · founded 2021 · 11 employees$35.2Mraised▾
Developer of robotic systems for hard-tissue surgery. The company focuses on humanoid-style robotic surgical platforms that combine robotics, navigation, AI, and automation to improve surgical precision and workflow efficiency. It is a specialized manufacturing company focused on advancing robotic surgery platforms.
- Jan 2024Series B$25.8M
- Dec 2022Series A$9.4M
#5
Series A · Nidau, Canton of Bern · founded 2013 · 8 employees$5.4Mraised▾
Developer of a blood-based IVD to test propensity for pathological calcification. In parallel, new therapies for the prevention of calcification are planned using the test kit for monitoring and guidance of personalized treatments. The T50-Test measures the maturation time of CalciProtein Particles (CPPs) by nephelometry. The test integrates the interplay of calcification inhibiting and promoting forces inherent in the blood into a single readout. The key target market is patients with chronic kidney disease stage 3–5 and those that are to undergo dialysis, and kidney transplantation. The T50-Test has already been shown to be highly predictive of patient survival, transplant graft failure, and the progression of aortic stiffness in kidney patients.
- Apr 2021Series A$2.7M
- Jul 2020Seed$644.3K
- 2015Seed—
- Apr 2014Seed—
#6
Acquired · Bern, Canton of Bern · founded 2000 · 41 employees$10.3Mraised▾
Developer of therapeutics to treat cancer. It develops a nanomedicine-based drug delivery system. Its product uses liposomal drug delivery technology. Its system can be combined with a large number of active ingredients and the design can be adapted to specific needs
- Jul 2018Series B$10.3M
#7
Seed · Thun, Canton of Bern · founded 2002 · 65 employees$314.6Kraised▾
Manufacturer of time of flight mass spectrometers for chemical analysis. It develops mass spectrometer instruments based on time-of-flight technology. Its features include complete mass spectra recording, high mass resolving power, simultaneous measurement of all isotope ratios, high-speed detection, and high sensitivity. It also offers software for data acquisition, post-processing, and integrated management of mass spectrometers. It has applications in atmosphere monitoring, geological surveys, soil analysis, as well as food and beverage and forensic sectors.
- May 2022Seed—
- Sep 2017Grant (prize money)$314.6K
#8
Acquired · Nidau, Canton of Bern · founded 2008 · 9 employees$156.7Kraised▾
Manufacturer of breathing muscle activation device
- Mar 2020Seed$156.7K
#9
Seed · Bern, Canton of Bern · founded 2009 · 65 employees$28.8Kraised▾
Developer of robotic and image-guided solutions for oncology and otology treatments. It provides solutions that allow clinicians to perform interventions and delivering outcomes from minimally invasive therapies. The products include CAS‑One IR an AI‑powered stereotactic navigation for tumor ablation procedure, HEARO a robotic platform for cochlear implantation, and OTOPLAN and OTODRIVE is a 3D inner‑ear imaging and surgical planning software for otology procedures.
- Nov 2016Grant (prize money)$293.2K
- 2010Seed$28.8K
- Seed—
#10
Funding Raised · Bern, Canton of Bern · founded 2021—raised▾
Developer of in-situ disinfection technology for preventing hospital acquired infections. It offers Far-UVC technology-based automated plug-and-play disinfection adaptors that prevent pathogenic colonization in and around different catheters.
- Apr 2024Grant (prize money)—
- Nov 2023Grant (prize money)—
#11
Funding Raised · Bern, Canton of Bern · founded 2015 · 15 employees—raised▾
Developer of organ-on-chip technologies to enable more efficient drug development. The lead product Lung-on-Chip system is an in-vitro model that closely mimics the biophysical characteristics of the lung, including the mechanical stress induced by respiration. This model is expected to best predict the effects of respiratory drug candidates in humans.
#12
Funding Raised · Zollikofen, Canton of Bern · founded 2017 · 3 employees—raised▾
Developer of novel molecular diagnostics designed to detect specific microorganisms and diseases. The company's diagnostic method amp is a reliable method for on-site detection of pathogens such as herpes or influenza viruses at their early stages, enabling healthcare providers to immediately diagnose diseases and carry out pathogen-specific therapies.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Switzerland
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 469 Switzerland-affiliated papers.
- ETH Zurich52
- University of Zurich40
- University of Lausanne34
- Agroscope30
- University of Basel30
- Gene2→9
- Chromatin1→8
- Antibody3→7
- Epitope1→5
- Immune system1→4
- Population2→4
- Antimicrobial1→5
- Context (archaeology)1→4
- Agriculture2→4
Where biotechnology is researched across Switzerland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.